SEC Form 4 · accession 0001179110-15-001899

GILEAD SCIENCES, INC. · GILD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, CFO

Period of report

Feb 2, 2015

Accepted (ET)

Feb 4, 2015 · 8:52 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000882095

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 2, 2015	M	11,550	$19.085	A	61,382	D
Common Stock	Feb 2, 2015	M	4,800	$23.755	A	66,182	D
Common Stock	Feb 2, 2015	M	11,250	$24.295	A	77,432	D
Common Stock	Feb 2, 2015	M	5,592	$40.56	A	83,024	D
Common Stock^F4	Feb 2, 2015	S	24,392	$105.1379	D	58,632	D
Common Stock^F5	Feb 2, 2015	S	8,200	$105.9789	D	50,432	D
Common Stock^F6	Feb 2, 2015	S	600	$106.8517	D	49,832	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)^F3	$19.085	Feb 2, 2015	M	11,550	D	—	Jan 20, 2021	Common Stock	11,550	0	D
Non-Qualified Stock Option (right to buy)^F2	$23.755	Feb 2, 2015	M	4,800	D	—	Jan 28, 2020	Common Stock	4,800	0	D
Non-Qualified Stock Option (right to buy)^F3	$24.295	Feb 2, 2015	M	11,250	D	—	Jan 26, 2022	Common Stock	11,250	45,000	D
Non-Qualified Stock Option (right to buy)^F3	$40.56	Feb 2, 2015	M	5,592	D	—	Feb 1, 2023	Commmon Stock	5,592	44,750	D

F1The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
F3The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F4Sale prices reported for the transactions reported here range from $104.63 to $105.62. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F5Sale prices reported for the transactions reported here range from $105.64 to $106.55. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F6Sale prices reported for the transactions reported here range from $106.71 to $107.07. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.